156 related articles for article (PubMed ID: 24152659)
1. MRI, enhanced CT, and FDG PET/CT in basal cell carcinoma of the prostate.
Dong A; Zuo C; Lu J; Wang Y
Clin Nucl Med; 2014 Aug; 39(8):721-4. PubMed ID: 24152659
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma of the prostate with strong FDG uptake on PET/CT.
Dong A; Zuo C; Lu J; Wang Y
Clin Nucl Med; 2014 Jul; 39(7):650-2. PubMed ID: 23877521
[TBL] [Abstract][Full Text] [Related]
3. MRI and FDG PET/CT findings of malignant fibrous histiocytoma of the prostate.
Dong A; Gong J; Wang Y; Zuo C
Clin Nucl Med; 2014 Oct; 39(10):889-91. PubMed ID: 24217548
[TBL] [Abstract][Full Text] [Related]
4. Malignant nonepithelial prostate tumors: FDG PET/CT findings with MRI and CT correlation.
Dong A; Zhang H; Wang Y; Gong J; Zuo C; Yang J; Lu J
Clin Nucl Med; 2015 Jan; 40(1):14-20. PubMed ID: 24999682
[TBL] [Abstract][Full Text] [Related]
5. 11C-Choline and 18F-FDG PET/CT in the Detection of Occult Prostate Cancer in the Context of a Paraneoplastic Syndrome.
Jiménez-Bonilla J; Quirce R; Banzo I; Martínez-Rodríguez I; Carril JM
Clin Nucl Med; 2015 Aug; 40(8):695-6. PubMed ID: 26018697
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.
Shiiba M; Ishihara K; Kimura G; Kuwako T; Yoshihara H; Sato H; Kondo Y; Tsuchiya S; Kumita S
Ann Nucl Med; 2012 Feb; 26(2):138-45. PubMed ID: 22069194
[TBL] [Abstract][Full Text] [Related]
7. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
8. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
[TBL] [Abstract][Full Text] [Related]
9. CT, MRI, and FDG-PET/CT imaging findings of abdominopelvic desmoplastic small round cell tumors: correlation with histopathologic findings.
Zhang WD; Li CX; Liu QY; Hu YY; Cao Y; Huang JH
Eur J Radiol; 2011 Nov; 80(2):269-73. PubMed ID: 20650589
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic Solitary Metastasis to the Testis From Prostate Carcinoma Detected by FDG PET/CT.
Hsieh TC; Lin CC; Kao CH; Wu YC; Sun SS
Clin Nucl Med; 2016 Jan; 41(1):86-7. PubMed ID: 26402135
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of the prostate lesions with increased FDG uptake on (18)F-FDG PET/CT.
Dong A; Bai Y; Wang Y; Zuo C; Lu J
Abdom Imaging; 2014 Aug; 39(4):908-21. PubMed ID: 24599406
[TBL] [Abstract][Full Text] [Related]
12. MRI, enhanced CT, and FDG PET/CT in primary retroperitoneal mucinous cystadenocarcinoma.
Dong A; Zhai Z; Wang Y; Zuo C
Clin Nucl Med; 2015 Jan; 40(1):50-3. PubMed ID: 24445275
[TBL] [Abstract][Full Text] [Related]
13. Primary Prostatic Extragastrointestinal Stromal Tumor on 18F-FDG PET/CT.
Liu Y; Xu B
Clin Nucl Med; 2016 Mar; 41(3):224-6. PubMed ID: 26402134
[TBL] [Abstract][Full Text] [Related]
14. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
Dong A; Dong H; Wang Y; Gong J; Lu J; Zuo C
Clin Nucl Med; 2013 Feb; 38(2):e66-73. PubMed ID: 22996250
[TBL] [Abstract][Full Text] [Related]
15. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
[TBL] [Abstract][Full Text] [Related]
16. FDG in Urologic Malignancies.
Høilund-Carlsen PF; Poulsen MH; Petersen H; Hess S; Lund L
PET Clin; 2014 Oct; 9(4):457-68, vi. PubMed ID: 26050947
[TBL] [Abstract][Full Text] [Related]
17. Quantitative graphical analysis of simultaneous dynamic PET/MRI for assessment of prostate cancer.
Rosenkrantz AB; Koesters T; Vahle AK; Friedman K; Bartlett RM; Taneja SS; Ding YS; Logan J
Clin Nucl Med; 2015 Apr; 40(4):e236-40. PubMed ID: 25608166
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of small cell carcinoma of the prostate.
Sahiner I; Akkas BE; Ucmak Vural G
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):193-5. PubMed ID: 23218515
[TBL] [Abstract][Full Text] [Related]
19. FDG PET/CT in primary pulmonary lymphoepithelioma-like carcinoma.
Dong A; Zhang J; Wang Y; Zhai Z; Zuo C
Clin Nucl Med; 2015 Feb; 40(2):134-7. PubMed ID: 24300356
[TBL] [Abstract][Full Text] [Related]
20. Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images?
Hwang I; Chong A; Jung SI; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K; Ryu SB
Ann Nucl Med; 2013 Feb; 27(2):140-5. PubMed ID: 23076866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
